FirstMark has a total of 39 patents globally, out of which 31 have been granted. Of these 39 patents, no patents are active. United States of America is where FirstMark has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of FirstMark.
FirstMark was founded in the year 2008. The Company makes venture capital and real estate investments either in the form of pure equity investments or in the form of loans with an equity participation feature.
Do read about some of the most popular patents of FirstMark which have been covered by us in this article and also you can find FirstMark patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over FirstMark patent portfolio.
How many patents does the founder and the CEO of FirstMark have?
The founders Gerald Poch has 0 patent, Lawrence Lenihan has 7 patents and Rick Heitzmann has 1 patent. The CEO Amish Jani has 0 patent.
How many patents does FirstMark have?
FirstMark has a total of 39 patents globally. These patents belong to 10 unique patent families. Out of 39 patents, no patents are active.
How Many Patents did FirstMark File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | FirstMark Applications Filed | FirstMark Patents Granted |
| 2012 | – | 2 |
| 2011 | – | 1 |
| 2010 | – | 2 |
| 2009 | – | 3 |
| 2008 | – | 2 |
| 2007 | – | 4 |
| 2006 | – | 6 |
| 2005 | – | 4 |
| 2004 | 2 | – |
| 2003 | 11 | 3 |
| 2002 | 7 | 4 |
How many FirstMark patents are Alive/Dead?
All the Patents were filed by FirstMark are Dead.
How Many Patents did FirstMark File in Different Countries?
All the Patents were filed by FirstMark in the United States of America.
Where are Research Centres of FirstMark Patents Located?
The Research Centre for all the FirstMark patents is the United States of America.
10 Best FirstMark Patents
US20020099578A1 is the most popular patent in the FirstMark portfolio. It has received 288 citations so far from companies like LG, Microsoft and Elnnovate.
Below is the list of 10 most cited patents of FirstMark:
| Publication Number | Citation Count |
| US20020099578A1 | 288 |
| US20020099598A1 | 215 |
| US6610026B2 | 198 |
| US6371974B1 | 173 |
| US20020099579A1 | 170 |
| US7192436B2 | 166 |
| US7175646B2 | 153 |
| US6846320B2 | 123 |
| US6527734B2 | 115 |
| US6544236B1 | 101 |
How many inventions of other companies were rejected due to FirstMark patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to FirstMark invention. They couldn’t because FirstMark had protected those before them.
Examiners at the USPTO referred 24 FirstMark patents in 176 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the FirstMark patent portfolio are Phillips, Boston Scientific Scimed and CYTYC.
List of the Companies whose Patents were rejected citing FirstMark –
| Company | Number of Patent Applications that faced Rejection Citing FirstMark Patents | Number of Rejections (102 & 103) |
| Phillips | 5 | 23 |
| Boston Scientific Scimed | 5 | 16 |
| CYTYC | 5 | 10 |
| IBM | 3 | 4 |
| Accessclosure | 3 | 5 |
| At&T | 2 | 2 |
| Medtronic | 2 | 6 |
| DCP | 2 | 2 |
| Silk Road Medical | 2 | 5 |
| Cardinal Health Switzerland | 1 | 2 |
Count of 102 and 103 Type Rejections based on FirstMark Patents
Top FirstMark Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US20020099578A1 | 14 |
| US20020099598A1 | 10 |
| US6984219B2 | 6 |
| US6610026B2 | 5 |
| US6863680B2 | 5 |
| US20020099580A1 | 3 |
| US7192436B2 | 3 |
| US6544236B1 | 3 |
| US6440153B2 | 2 |
| US7621936B2 | 2 |
| US7611479B2 | 2 |
| US6849232B2 | 2 |
| US7625352B1 | 2 |
| US7175646B2 | 2 |
| US7695492B1 | 2 |
List of FirstMark patents
| FirstMark Patents | Title |
| US8317821B1 | Release Mechanism |
| US8187625B2 | Cross-Linked Gelatin Composition Comprising A Wetting Agent |
| US7955353B1 | Dissolvable Closure Device |
| US7753872B2 | Device, System And Method For Improving Delivery Of Hemostatic Material |
| US7695492B1 | Enhanced Bleed Back System |
| US7625352B1 | Depth And Puncture Control For System For Hemostasis Of Blood Vessel |
| US7621936B2 | Sheath-Mounted Arterial Plug Delivery Device |
| US7611479B2 | System And Method For Facilitating Hemostasis Of Blood Vessel Punctures With Absorbable Sponge |
| US7455680B1 | Apparatus And Method For Inhibiting Blood Loss |
| US7335219B1 | Hemostatic Device Including A Capsule |
| US7201725B1 | Device And Method For Determining A Depth Of An Incision |
| US7192436B2 | Pledget-Handling System And Method For Delivering Hemostasis Promoting Material To A Blood Vessel Puncture Site By Fluid Pressure |
| US7175646B2 | Apparatus And Method For Percutaneous Sealing Of Blood Vessel Punctures |
| US7159716B2 | Easy Cutter |
| US7048710B1 | System And Method For Facilitating Hemostasis Of Blood Vessel Punctures With Absorbable Sponge |
| US7037322B1 | System And Method For Delivering Hemostasis Promoting Material To A Blood Vessel Puncture With A Staging Tube |
| US7037323B2 | Pledget-Handling System And Method For Delivering Hemostasis Promoting Material To A Blood Vessel Puncture Site By Fluid Pressure |
| US7029489B1 | System And Method For Delivering Hemostasis Promoting Material To A Blood Vessel Puncture Site |
| US7008440B2 | System And Method For Delivering Hemostasis Promoting Material To A Blood Vessel Puncture Site By Fluid Pressure |
| US6984219B2 | Depth And Puncture Control For Blood Vessel Hemostasis System |
| US6964658B2 | System And Method For Facilitating Hemostasis Of Blood Vessel Punctures With Absorbable Sponge |
| US6863680B2 | System And Method For Delivering Hemostasis Promoting Material To A Blood Vessel Puncture Site By Fluid Pressure |
| US6849232B2 | Methods For Sterilizing Cross-Linked Gelatin Compositions |
| US6846320B2 | Device And Method For Facilitating Hemostasis Of A Biopsy Tract |
| US20040102730A1 | System And Method For Facilitating Hemostasis Of Blood Vessel Punctures With Absorbable Sponge |
| US20040018193A1 | Rapid-Acting Broad Spectrum Protection Against Biological Threat Agents |
| US20030224403A1 | Lethal Toxin Cytopathogenicity And Novel Approaches To Anthrax Treatment |
| US6610026B2 | Method Of Hydrating A Sponge Material For Delivery To A Body |
| US6544236B1 | Device, System And Method For Improving Delivery Of Hemostatic Material |
| US6527734B2 | System And Method For Facilitating Hemostasis Of Blood Vessel Punctures With Absorbable Sponge |
| US6447534B2 | Device And Method For Facilitating Hemostasis Of A Biopsy Tract |
| US6440151B1 | Device And Method For Facilitating Hemostasis Of A Biopsy Tract |
| US6440153B2 | Device And Method For Facilitating Hemostasis Of A Biopsy Tract |
| US20020099579A1 | Stateless, Event-Monitoring Architecture For Performance-Based Supply Chain Management System And Method |
| US20020099598A1 | Performance-Based Supply Chain Management System And Method With Metalerting And Hot Spot Identification |
| US20020099578A1 | Performance-Based Supply Chain Management System And Method With Automatic Alert Threshold Determination |
| US20020099580A1 | Performance-Based Supply Chain Management System And Method With Collaboration Environment For Dispute Resolution |
| US6371974B1 | Apparatus And Method For Percutaneous Sealing Of Blood Vessel Punctures |
| US20020038133A1 | Absorbable Sponge With Contrasting Agent |